SaveRxCanada.to Offers India-Sourced Ozempic at Lower Prices for U.S. Patients

SaveRxCanada.to has announced the availability of Ozempic sourced from India, expanding its portfolio of prescription medicines for U.S. patients looking for more affordable alternatives amid rising domestic pharmacy costs.

Ozempic (semaglutide), manufactured by Novo Nordisk, is commonly prescribed in the United States, where out-of-pocket prices at retail pharmacies typically range from $900 to $1,100 per pen, depending on dosage and location. As per media reports, the pricing published on SaveRxCanada.to, Ozempic from India is listed starting at around $280 per pen, with lower per-unit pricing available for multi-pen orders.

The platform offers Ozempic in multiple prefilled pen strengths, enabling patients to purchase the dosage prescribed by their healthcare provider. Based on current listings, patients may see price differences of $700 or more per pen compared with widely reported U.S. retail prices. Bulk purchases further reduce the average per-pen cost, providing an option for patients seeking greater price predictability and longer-term treatment planning.

All orders include free shipping, and product listings clearly state the manufacturer and country of origin. A valid prescription is required for all Ozempic purchases.

Also Read